Clinical trial
Safety, Efficacy and Pharmacokinetics of OPC-67683 in Patients With Pulmonary…
NCT00401271 · Otsuka Frankfurt Research Institute GmbH, Industry · Completed
Key facts
| NCT number | NCT00401271 |
|---|---|
| Title | Safety, Efficacy and Pharmacokinetics of OPC-67683 in Patients With Pulmonary Tuberculosis |
| Official title | A Phase II Trial to Evaluate the Safety, Efficacy and Pharmacokinetics of Four Oral Doses of OPC-67683 in Patients With Uncomplicated, Smear-Positive, Pulmonary Tuberculosis |
| Lead sponsor | Otsuka Frankfurt Research Institute GmbH, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pulmonary Tuberculosis |
| Intervention type | Drug |
| Interventions | OPC-67683, Rifafour e-275 |
| Enrollment | 54 |
| Start date | Nov 1, 2006 |
| Completion | Mar 1, 2007 |
| First posted | Nov 20, 2006 |
| Last update posted | Mar 7, 2007 |
| Countries | South Africa |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: